Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News DaVita Inc DVA

Healthcare
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers... see more

Recent & Breaking News (NYSE:DVA)

DaVita Inc. Announces Add-On Offering of $750 Million Senior Notes

PR Newswire February 24, 2021

DaVita Inc. 4th Quarter 2020 Results

PR Newswire February 11, 2021

DVA Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Davita Inc (NYSE:DVA) Investors

PR Newswire February 6, 2021

DaVita Inc. Schedules 4th Quarter 2020 Investor Conference Call

PR Newswire January 29, 2021

Early Risk Identification at Core of Innovative Kidney Care Partnership Between Renalytix, DaVita

GlobeNewswire January 5, 2021

DaVita Celebrates 100,000 Patients Receiving Kidney Transplants

PR Newswire December 22, 2020

14th Annual Tour DaVita Raises Nearly $1 Million for Bridge of Life

PR Newswire November 23, 2020

DaVita Responds to Proposition 23 in California

PR Newswire November 4, 2020

DaVita Inc. 3rd Quarter 2020 Results

PR Newswire October 29, 2020

DaVita Clinical Research to Present New Findings at American Society of Nephrology Kidney Week 2020

PR Newswire October 22, 2020

DaVita Inc. Schedules 3rd Quarter 2020 Investor Conference Call

PR Newswire October 15, 2020

DaVita Announces Final Results Of Self-Tender Offer

PR Newswire September 17, 2020

DaVita Announces Preliminary Results of Self-Tender Offer

PR Newswire September 15, 2020

DaVita Announces Shawn Guertin Will Join its Board of Directors

PR Newswire September 8, 2020

DaVita Opens Its Doors to Hurricane Laura Evacuees Needing Dialysis

PR Newswire August 27, 2020

Clinical Research Trials Underway to Study COVID-19 Impact on Dialysis Patients

PR Newswire August 20, 2020

DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common Stock

PR Newswire August 17, 2020

Myriad Genetics Appoints Paul J. Diaz as President and Chief Executive Officer and a Member of the Board of Directors

GlobeNewswire August 13, 2020

DaVita Expands Initiative to Advance Nursing Education

PR Newswire August 13, 2020

DaVita Announces Paula A. Price to Join its Board of Directors

PR Newswire August 11, 2020